Amarin Corporation plc
First Floor Block 3
The Oval Shelbourne Road Ballsbridge
Dublin,
4
Ireland - Map
Phone: 353 1 669 9020
Fax: 353 1 669 9028
Web Site: http://www.amarincorp.com
| Amarin Corporation plc, a biopharmaceutical company, engages in the research, development, and commercialization of drugs for patients suffering from central nervous system (CNS) and cardiovascular diseases. The company’s CNS development pipeline includes AMR101, a semi-synthetic and highly purified derivative of 5,8,11,14,17-eicosapentaenoic acid for the treatment of dyslipidemia and Huntington's disease; EN101, an orally available antisense oligonucleotide for myasthenia gravis; sublingual Apomorphine for Parkinson's disease; Nasal Lorazepam for the treatment of emergency seizures in epilepsy patients; and AMR101 to treat associated memory impairment. In addition, it has two proprietary technology platforms, which include targeted lipid transport technology platform for the targeted transport of molecules through the liver and/or to the brain; and messenger RNA technology based on cholinergic neuromodulation. Amarin Corporation operates in the United Kingdom and internationally. The company has a collaboration agreement with ProSeed Capital Holdings CVA. Amarin Corporation plc, formerly known as Ethical Holdings plc, was founded in 1989 and is based in Dublin, Ireland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Thomas Lynch , 51
Chairman and Chief Exec. Officer |
N/A
| N/A | Mr. Alan Cooke , 37
Pres, Chief Operating Officer and Chief Financial Officer |
N/A
| N/A | Dr. Declan Doogan M.D., 56
Head of R&D |
$
245.00K | N/A | Mr. Conor Dalton , 43
Principal Accounting Officer and VP of Fin. |
N/A
| N/A | Mr. Tom Maher , 41
Company Sec. and Gen. Counsel |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.28% Nasdaq 
Profile
